| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.08 | 0.09 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.35 | 0.1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.084 | 0.1 |